Anders M. Galloe - Publications

Predictors of 10-Year Stent-Related Adverse Outcomes after Coronary Drug-Eluting Stent Implantation: The Importance of Stent Size.

Journal: Cardiology

Published: January 25, 2021

SuPAR is associated with death and adverse cardiovascular outcomes in patients with suspected coronary artery disease.

Journal: Scandinavian cardiovascular journal : SCJ

Published: May 14, 2020

Ten-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segments.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: July 04, 2018

10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents.

Journal: Journal of the American College of Cardiology

Published: July 28, 2016

Stent thrombosis is the primary cause of ST-segment elevation myocardial infarction following coronary stent implantation: a five year follow-up of the SORT OUT II study.

Journal: PloS one

Published: July 12, 2014

Similar five-year outcome with paclitaxel- and sirolimus-eluting coronary stents.

Journal: Scandinavian cardiovascular journal : SCJ

Published: February 20, 2014

Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: Nordic Bifurcation Study 5-year follow-up results.

Journal: Journal of the American College of Cardiology

Published: January 14, 2013

Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results.

Journal: JACC. Cardiovascular interventions

Published: December 18, 2012